[go: up one dir, main page]

WO2010044597A2 - Drug delivery device - Google Patents

Drug delivery device Download PDF

Info

Publication number
WO2010044597A2
WO2010044597A2 PCT/KR2009/005891 KR2009005891W WO2010044597A2 WO 2010044597 A2 WO2010044597 A2 WO 2010044597A2 KR 2009005891 W KR2009005891 W KR 2009005891W WO 2010044597 A2 WO2010044597 A2 WO 2010044597A2
Authority
WO
WIPO (PCT)
Prior art keywords
delivery device
drug delivery
hard capsule
present
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2009/005891
Other languages
French (fr)
Korean (ko)
Other versions
WO2010044597A3 (en
Inventor
김성욱
전성수
구자성
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanall Pharmaceutical Co Ltd
Original Assignee
Hanall Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanall Pharmaceutical Co Ltd filed Critical Hanall Pharmaceutical Co Ltd
Publication of WO2010044597A2 publication Critical patent/WO2010044597A2/en
Publication of WO2010044597A3 publication Critical patent/WO2010044597A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

The present invention provides a drug delivery device comprising a hard capsule and a micro-aperture penetrating through the wall of the hard capsule. The interior of the hard capsule contains an immediate-release compartment and an extended-release compartment. The drug delivery device of the present invention is greatly effective in releasing one or more drugs which require controlled release in the body.
PCT/KR2009/005891 2008-10-14 2009-10-14 Drug delivery device Ceased WO2010044597A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10514008P 2008-10-14 2008-10-14
US61/105,140 2008-10-14

Publications (2)

Publication Number Publication Date
WO2010044597A2 true WO2010044597A2 (en) 2010-04-22
WO2010044597A3 WO2010044597A3 (en) 2010-07-29

Family

ID=42107046

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/005891 Ceased WO2010044597A2 (en) 2008-10-14 2009-10-14 Drug delivery device

Country Status (1)

Country Link
WO (1) WO2010044597A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100468334B1 (en) * 1996-04-05 2005-03-16 앨자 코포레이션 Uniform Drug Deliver Therapy
KR100504013B1 (en) * 2003-02-28 2005-07-28 한국유나이티드제약 주식회사 Controlled release pellets for oral and it's manufacturing process
KR20080031050A (en) * 2005-08-05 2008-04-07 바이엘 쉐링 파마 악티엔게젤샤프트 Pharmaceutical formulations in which the active ingredient is PH-independently delayed release to the active ingredient having high pH-dependent solubility
KR100888131B1 (en) * 2006-10-10 2009-03-11 한올제약주식회사 Combination preparation for Cardiovascular disease therapy by Chronotherapy theory.

Also Published As

Publication number Publication date
WO2010044597A3 (en) 2010-07-29

Similar Documents

Publication Publication Date Title
EP4056173A3 (en) Swallowable drug delivery device
EP2500044A3 (en) Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
WO2010030728A3 (en) Devices and systems for delivery of therapeutic agents to body lumens
WO2020106704A3 (en) Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
WO2010057082A3 (en) Diagnostic capsules, delivery/retrieval systems, kits and methods
WO2010111232A3 (en) Drug delivery medical device
WO2007013059A3 (en) Extending intrabody capsule
WO2011080141A3 (en) Degradable removable implant for the sustained release of an active compound
EP2092941A3 (en) Drug releasing coatings for medical devices
WO2012009684A3 (en) Drug delivery medical device
WO2007092390A3 (en) Devices and methods for gastrointestinal stimulation
WO2008036549A3 (en) Medical devices
WO2010014690A3 (en) Medical devices for therapeutic agent delivery
WO2008090549A3 (en) Extending intrabody capsule
ZA201003779B (en) Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens
WO2010129545A3 (en) Porous silicon drug-eluting particles
WO2006069677A3 (en) Combination comprising an agent providing a signal, an implant material and a drug
WO2009049184A9 (en) Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors
WO2009120792A3 (en) Anchor and anchor deployment apparatus
WO2004087011A3 (en) Therapeutic agent delivery device with controlled therapeutic agent release rates
WO2005118036A3 (en) Systems and methods for the administration of drugs and medications
WO2010042471A3 (en) Medical devices for delivery of therapeutic agents to body lumens
WO2010082993A3 (en) Systems, methods, and devices using stretchable or flexible electronics for medical applications
EP2954916A3 (en) Clinical and/or consumer techniques and devices
CA2873879A1 (en) Vascular occlusion and drug delivery devices, systems, and methods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09820747

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09820747

Country of ref document: EP

Kind code of ref document: A2